Veterinary Surgical Oncology. Группа авторов

A, D.P. Taylor, and D.J. Simpson. 2016. Clinical, computed tomographic, magnetic resonance imaging, and histologic findings associated with myxomatous neoplasia of the temporomandibular joint in two dogs. J Am Vet Med Assoc 249(11):1301–1307.

      290 Patnaik, A.K., W.J. Ehler, and E.G. MacEwen. 1984. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 21(5):469–474.

      291 Patterson, C.C., R.L. Perry, and B. Steficek. 2008. Malignant peripheral nerve sheath tumor of the diaphragm in a dog. J Am Anim Hosp Assoc 44(1):36–40.

      292 Pavletic, M.M. 2000. Use of an external skin‐stretching device for wound closure in dogs and cats. J Am Vet Med Assoc 217(3):350–354.

      293 Pavletic, M.M. 2003. Chapter 23—Pedicle grafts. In Textbook of Small Animal Surgery, 3rd edition. D.H. Slatter, editor. Philadelphia: Saunders.

      294 Pavletic, M.M. 2018. Atlas of Small Animal Wound Management and Reconstructive Surgery. Hoboken: John Wiley & Sons.

      295 Perry, J.A., W.T. Culp, D.D. Dailey, et al. 2014. Diagnostic accuracy of pre‐treatment biopsy for grading soft tissue sarcomas in dogs. Vet Comp Oncol 12:106–113.

      296 Petznek, H., M. Kleiter, A. Tichy, et al. 2014. Murine xenograft model demonstrates significant radio‐sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma. Res Vet Sci 97(2):386–390.

      297 Phelps, H.H., C.A. Kuntz, R.J. Milner, et al. 2011. Radical excision with five‐centimeter margins for treatment of feline injection‐site sarcomas: 91 cases (1998–2002). J Am Vet Med Assoc 239(1):97–106.

      298 Pierini, A., F. Cinti, D. Binanti, et al. 2017. Primary leiomyosarcoma of the jugular vein in a dog. Open Vet J 7(1):61–64.

      299 Pizzoni, S., S. Sabattini, D. Stefanello, et al. 2018. Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study. Vet Comp Oncol 16(1):28–36.

      300 Plavec, T., M. Kessler, B. Kandel, et al. 2006. Palliative radiotherapy as treatment for non‐resectable soft tissue sarcomas in the dog – a report of 15 cases. Vet Comp Oncol 4(2):98–103.

      301 Poirier, V.J., W.M. Adams, L.J. Forrest, et al. 2006. Radiation therapy for incompletely excised grade II canine mast cell tumors. J Am Anim Hosp Assoc 42(6):430–434.

      302 Powers, B.E., P.J. Hoopes, and E.J. Ehrhart. 1995. Tumor diagnosis, grading, and staging. Semin Vet Med Surg (Small Anim) 10(3):158–167.

      303 Porcellato, I., C. Brachelente, L. De Paolis, et al. 2019. FoxP3 and IDO in canine melanocytic tumors. Vet Pathol 56:189–199.

      304 Pratschke, K.M., M.J. Atherton, J.A. Sillito, et al. 2013. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008–2012). J Am Vet Med Assoc 243(10):1436–1441.

      305 Prpich, C.Y., A.C. Santamaria, J.O. Simcock, et al. 2014. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005–2012). J Am Vet Med Assoc 244:187–194.

      306 Quintin‐Colonna, F., P. Devauchelle, D. Fradelizi, et al. 1996. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin‐2. Gene Ther 3(12):1104–1112.

      307 Ranganathan, B., M. Milovancev, H. Leeper, et al. 2018. Inter‐ and intra‐rater reliability and agreement in determining subcutaneous tumour margins in dogs. Vet Comp Oncol 16(3):392–398.

      308 Raposio, E., M. Antonacci, and G. Caruana. 2014. A simple technique for the excision of cutaneous carcinoma: The round block purse‐string suture. World J Surg Oncol 12:263.

      309 Rassnick, K.M. 2003. Medical management of soft tissue sarcomas. Vet Clin North Am Small Anim Pract 33(3):517–531.

      310 Rassnick, K.M., D.B. Bailey, A.B. Flory, et al. 2008. Efficacy of vinblastine for treatment of canine mast cell tumors. J Vet Intern Med 22(6):1390–1396.

      311 Rassnick, K.M., A.S. Moore, L.E. Williams, et al. 1999. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 13(6):601–605.

      312 Rassnick, K.M., D.M. Ruslander, S.M. Cotter, et al. 2001. Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000). J Am Vet Med Assoc 218(9):1444–1448.

      313 Rayner, E.L., C.L. Scudamore, I. Francis, et al. 2010. Abdominal fibrosarcoma associated with a retained surgical swab in a dog. J Comp Pathol 143(1):81–85.

      314 Reynolds, B.D., M.J. Thomson, K. O'Connell, et al. 2019. Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index. Vet Comp Oncol 17(3):338–344.

      315 Risselada, M., K.G. Mathews, and E. Griffith. 2015. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010–2013). J Am Vet Med Assoc 247(2):184–189.

      316 Robertson, E.G. and G. Baxter. 2011. Tumor seeding following percutaneous needle biopsy: The real story! Clin Radiol 66:1007–1014.

      317 Rohrborn, A. and H.D. Roher. 1998. Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas. Praxis (Bern 1994) 87(34):1050–1060.

      318 Romanelli, G., L. Marconato, D. Olivero, et al. 2008. Analysis of prognostic factors associated with injection‐site sarcomas in cats: 57 cases (2001–2007). J Am Vet Med Assoc 232(8):1193–1199.

      319 Romansik, E.M., C.M. Reilly, P.H. Kass, et al. 2007. Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44(3):335–341.

      320 Rousset, N., M.A. Holmes, A. Caine, et al. 2013. Clinical and low‐field MRI characteristics of injection site sarcoma in 19 cats. Vet Radiol Ultrasound 54(6):623–629.

      321 Rossi, F., M. Korner, J. Suarez, et al. 2018. Computed tomographic‐lymphography as a complementary technique for lymph node staging in dogs with malignant tumors of various sites. Vet Radiol Ultrasound 59(2):155–162.

      322 Sabattini, S., M. Giantin, A. Barbanera, et al. 2016. Feline intestinal mast cell tumours: Clinicopathological characterisation and KIT mutation analysis. J Feline Med Surg 18:280–289.

      323 Sabattini, S. and G. Bettini. 2019. Grading cutaneous mast cell tumors in cats. Vet Pathol 56(1):43–49.

      324 Sabattini, S., A. Renzi, L. Marconato, et al. 2018. Comparison between May‐Grunwald‐Giemsa and rapid cytological stains in fine‐needle aspirates of canine mast cell tumour: Diagnostic and prognostic implications. Vet Comp Oncol 16(4):511–517.

      325 Salgüero, R., J. Demetriou, F. Constantino‐Casas, et al. 2015. Hypertrophic osteopathy in a cat with a concurrent injection‐site sarcoma. JFMS Open Rep 1(2) https://doi.org/10.1177%2F2055116915593968.

      326 Sanchez, A., A. Valverde, M. Sinclair, et al. 2017. Antihistaminic and cardiorespiratory effects of diphenhydramine hydrochloride in anesthetized dogs undergoing excision of mast cell tumors. J Am Vet Med Assoc 251(7):804–813.

      327 Saunders, H., M.J. Thomson, K. O’Connell, et al. 2020. Evaluation of a modified proportional margin approach for complete surgical excision of canine cutaneous mast cell tumours and its associated clinical outcome. Vet Comp Oncol doi:10.1111/vco.12630. Online ahead of print.

      328 Sawamoto, O., J. Yamate, M. Kuwamura, et al. 1999. A canine peripheral nerve sheath tumor including peripheral nerve fibers. J Vet Med Sci 61(12):1335–1338.

      329 Scarpa, F., S. Sabattini, and G. Bettini. 2016. Cytological grading of canine cutaneous mast cell tumours. Vet Comp Oncol 14(3):245–251.

      330 Scase, T.J., D. Edwards, J. Miller, et al. 2006. Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med 20(1):151–158.

      331 Scavelli, T.D., A.K. Patnaik, C.J. Mehlhaff, et al. 1985. Hemangiosarcoma in the